Journal of Pathology

Papers
(The H4-Index of Journal of Pathology is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats104
Issue Information89
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation87
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer84
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer79
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma78
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy71
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance70
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment61
Clinical outcomes and immune contexture in SMARCA4 ‐deficient gastric cancer patients58
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors55
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities53
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients50
Artificial intelligence to identify genetic alterations in conventional histopathology49
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells45
Presence of Tim3+ and PD‐1+CD8+T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di44
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma43
Escape from senescence: molecular basis and therapeutic ramifications43
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response42
Pseudobudding: ruptured glands do not represent true tumor buds42
CRISPR –Cas9 screening identifies the role of FER as a tumor suppressor40
39
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT138
Integrating computational pathology and proteomics to address tumor heterogeneity37
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and 35
Identification of actionable targets using DEPArray ‐based sorting of pure carcinoma and stromal populations from formalin‐fixed paraffin‐embedded ti35
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells35
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer35
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer34
Field cancerization in breast cancer34
KMT2D deficiency potentiates antitumor immunity and sensitizes immune checkpoint blockade in urologic cancers33
Minigene‐based splicing analysis and ACMG/AMP‐based tentative classification of 56 ATM variants32
0.17399501800537